Latest Breaking News On - Matt trerotola - Page 15 : comparemela.com

Colfax has committed to separating its medical device and fabrication technology businesses into two independent public companies. The split will create a medtech company with a portfolio of orthopaedic devices forecast to generate sales of around $1.4 billion this year.  Colfax expects to complete the split by the first quarter of next year.  Colfax built the portfolio through its $3.15 billion takeover of DJO Global and subsequent deals for Stryker s STAR total ankle replacement product, LiteCure and Trilliant Surgical. Splitting the businesses is intended to facilitate more M&A. Dive Insight: Colfax was an industrial technology conglomerate targeting the welding and air and gas handling sectors before it made its $3.15 billion move for DJO late in 2018. The deal moved Colfax into a new industry, albeit one that its founders and CEO had some experience from their time working at Danaher. Colfax then expanded DJO through deals for ankle replacement products, therapeutic laser

United statesMatt trerotolaBrady shirleyDive briefMedical devicesM amp aஒன்றுபட்டது மாநிலங்களில்பிராடி ஷெர்லிடைவ் சுருக்கமானமருத்துவ சாதனங்கள்